Literature DB >> 16644364

A review of anterior segment dysgeneses.

Faisal Idrees1, Daniela Vaideanu, Scott G Fraser, Jane C Sowden, Peng T Khaw.   

Abstract

The anterior segment dysgeneses are an ill-defined group of ocular developmental abnormalities that share some common features and have a high prevalence of glaucoma. Current classification of what are and what are not anterior segment dysgeneses seems to vary and our knowledge of them is incomplete. As the limits of classical clinical medicine based on evaluation of signs and symptoms are reached, further advancements increasingly will come from molecular medicine and genetics. In this article we review the normal and abnormal development of the anterior segment (concentrating primarily upon neural crest derived dysgeneses), describe the various clinical entities produced and their diagnosis, and discuss the current knowledge of the genetics of these disorders. We also suggest a new approach to the classification of anterior segment dysgeneses, based upon the embryological contribution to the formation of the anterior segment of the eye.

Entities:  

Mesh:

Year:  2006        PMID: 16644364     DOI: 10.1016/j.survophthal.2006.02.006

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  50 in total

1.  X-linked megalocornea caused by mutations in CHRDL1 identifies an essential role for ventroptin in anterior segment development.

Authors:  Tom R Webb; Mar Matarin; Jessica C Gardner; Dan Kelberman; Hala Hassan; Wei Ang; Michel Michaelides; Jonathan B Ruddle; Craig E Pennell; Seyhan Yazar; Chiea C Khor; Tin Aung; Mahinda Yogarajah; Anthony G Robson; Graham E Holder; Michael E Cheetham; Elias I Traboulsi; Anthony T Moore; Jane C Sowden; Sanjay M Sisodiya; David A Mackey; Stephen J Tuft; Alison J Hardcastle
Journal:  Am J Hum Genet       Date:  2012-01-26       Impact factor: 11.025

Review 2.  Axenfeld-Rieger syndrome and spectrum of PITX2 and FOXC1 mutations.

Authors:  Zeynep Tümer; Daniella Bach-Holm
Journal:  Eur J Hum Genet       Date:  2009-06-10       Impact factor: 4.246

3.  A Chinese family with Axenfeld-Rieger syndrome: report of the clinical and genetic findings.

Authors:  Da-Peng Sun; Yun-Hai Dai; Xiao-Jing Pan; Tao Shan; Dian-Qiang Wang; Peng Chen
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

4.  Novel Ocular and Inner Ear Anomalies in a Patient with Myhre Syndrome.

Authors:  Semra Gürsoy; Filiz Hazan; Tülay Öztürk; Halil Ateş
Journal:  Mol Syndromol       Date:  2019-12-20

5.  Mutations of conserved non-coding elements of PITX2 in patients with ocular dysgenesis and developmental glaucoma.

Authors:  Meredith E Protas; Eric Weh; Tim Footz; Jay Kasberger; Scott C Baraban; Alex V Levin; L Jay Katz; Robert Ritch; Michael A Walter; Elena V Semina; Douglas B Gould
Journal:  Hum Mol Genet       Date:  2017-09-15       Impact factor: 6.150

6.  Identification of a novel frameshift mutation in PITX2 gene in a Chinese family with Axenfeld-Rieger syndrome.

Authors:  Hou-fa Yin; Xiao-yun Fang; Chong-fei Jin; Jin-fu Yin; Jin-yu Li; Su-juan Zhao; Qi Miao; Feng-wei Song
Journal:  J Zhejiang Univ Sci B       Date:  2014-01       Impact factor: 3.066

7.  Loss of Msx2 function down-regulates the FoxE3 expression and results in anterior segment dysgenesis resembling Peters anomaly.

Authors:  Jiangyue Zhao; Kirio Kawai; Hongyan Wang; Di Wu; Mingwu Wang; Zhicao Yue; Jinsong Zhang; Yi-Hsin Liu
Journal:  Am J Pathol       Date:  2012-04-13       Impact factor: 4.307

8.  Lmx1b is required for murine trabecular meshwork formation and for maintenance of corneal transparency.

Authors:  Pu Liu; Randy L Johnson
Journal:  Dev Dyn       Date:  2010-08       Impact factor: 3.780

9.  A novel mutation of PAX6 in Chinese patients with new clinical features of Peters' anomaly.

Authors:  Xiuhua Jia; Xiangming Guo; Xiaoyun Jia; Xueshan Xiao; Shiqiang Li; Qingjiong Zhang
Journal:  Mol Vis       Date:  2010-04-15       Impact factor: 2.367

10.  Pharmacogenetics of ophthalmic topical beta-blockers.

Authors:  Duska J Sidjanin; Catherine A McCarty; Richard Patchett; Edward Smith; Russell A Wilke
Journal:  Per Med       Date:  2008       Impact factor: 2.512

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.